Transplanting
cells from aborted foetuses was shown to reverse the effects of the
progressive neurological condition in studies in the 1990s but trials were
abandoned because the results were unpredictable.
While some
patients found some relief from tremors, rigidity and slowness of movement
following surgery, others developed jerky, involuntary movements known as
dyskinesias.
The
side effect was so serious that the human trials were halted in 2001.
Researchers
funded by the Medical Research Council (MRC) and Imperial College London
now believe dyskinesia was caused by malfunctioning serotonin cells and
say the disorder can be treated with drugs.
Dr Marios
Politis from MRC Clinical Sciences Centre at Imperial College London, who
led the research team, said: "After the huge excitement surrounding
the potential of brain cell transplants in the 1990s, we are thrilled that
this discovery could reopen the door to this promising area of research.
"We
know that the benefits of this treatment could last up to 16 years, and we
look forward to bringing this treatment one step closer to a reality for
Parkinson's patients."
Dr Politis
said earlier trials showed the surgery could produce "remarkable
improvement" in some patients but the majority suffered serious
disabling adverse effects.
He said
dyskinesia is a common side effect of drugs used to treat the symptoms of
Parkinson's disease but the patients were suffering involuntary
uncontrolled movements while off their drugs.
The new
research, which is published online today in Science Translational
Medicine, scanned the brains of two Parkinson's sufferers who suffered
dyskinesia following surgery.
Dr Politis
said researchers found the side effect was the result of an overabundance
of serotonin cells in the transplanted tissue.
This could
be prevented through drugs, he said, adding that the team suggested
serotonin cells be removed during the preparation of transplanted tissue
in future trials which they hope will now be able to take place.
Dr Politis
said the findings represent "a major advance in the field of cell
therapy for Parkinson's disease".
The
transplant is not currently available as an option for treatment in the
UK
.
There is
currently no cure for Parkinson's, which affects around 120,000 people in
the
UK
, according to the charity Parkinson's
UK
.
People
with Parkinson's do not have enough of the chemical dopamine because some
nerve cells in their brain have died but it is not yet known why that
happens.
More
Information on World Health Issues
Copyright © Global Action on Aging
Terms of Use |
Privacy Policy | Contact
Us